Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BORREBY DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.0% 3.5% 4.1% 2.4% 3.9% 4.1% 13.7% 13.5%   Credit score (0-100)   59 54 49 62 50 48 16 17   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,997 2,124 2,833 2,977 3,040 2,801 0.0 0.0   EBITDA   204 135 82.0 316 164 291 0.0 0.0   EBIT   16.0 -64.0 -119 104 -23.0 154 0.0 0.0   Pre-tax profit (PTP)   -31.0 -24.0 -160.0 141.0 -93.0 94.0 0.0 0.0   Net earnings   -25.0 -19.0 -125.0 109.0 -73.0 73.3 0.0 0.0   Pre-tax profit without non-rec. items   -31.0 -24.0 -160 141 -93.0 94.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,323 1,141 1,007 795 607 470 0.0 0.0   Shareholders equity total   1,471 1,452 1,327 1,436 913 985 785 785   Interest-bearing liabilities   656 255 885 150 2,649 2,898 0.0 0.0   Balance sheet total (assets)   2,781 2,502 3,722 2,400 4,179 4,655 785 785   Net Debt   -300 -501 -1,349 -617 -323 -625 -785 -785     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,997 2,124 2,833 2,977 3,040 2,801 0.0 0.0   Gross profit growth   14.6% 6.4% 33.4% 5.1% 2.1% -7.9% -100.0% 0.0%   Employees   4 6 7 7 6 5 0 0   Employee growth %   0.0% 50.0% 16.7% 0.0% -14.3% -16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,781 2,502 3,722 2,400 4,179 4,655 785 785   Balance sheet change%   -17.4% -10.0% 48.8% -35.5% 74.1% 11.4% -83.1% 0.0%   Added value   204.0 135.0 82.0 316.0 189.0 291.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -139 -381 -335 -424 -375 -274 -470 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.8% -3.0% -4.2% 3.5% -0.8% 5.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   1.0% -0.3% -3.4% 5.1% -0.2% 5.0% 0.0% 0.0%   ROI %   1.3% -0.4% -5.3% 8.0% -0.3% 5.9% 0.0% 0.0%   ROE %   -1.7% -1.3% -9.0% 7.9% -6.2% 7.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   52.9% 58.0% 35.7% 59.8% 21.8% 21.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -147.1% -371.1% -1,645.1% -195.3% -197.0% -214.5% 0.0% 0.0%   Gearing %   44.6% 17.6% 66.7% 10.4% 290.1% 294.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.3% 3.5% 9.3% 2.7% 6.1% 4.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.9 0.9 1.0 1.3 1.0 1.0 0.0 0.0   Current Ratio   1.2 1.4 1.1 1.8 1.1 1.1 0.0 0.0   Cash and cash equivalent   956.0 756.0 2,234.0 767.0 2,972.0 3,522.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -37.0 81.0 63.0 381.0 59.0 256.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   51 23 12 45 32 58 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   51 23 12 45 27 58 0 0   EBIT / employee   4 -11 -17 15 -4 31 0 0   Net earnings / employee   -6 -3 -18 16 -12 15 0 0